This inventor holds 1 USPTO granted patent. Top assignee: Novartis Tiergesundheit Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Emilie Dupont: Innovator in Ectoparasite Control
Introduction
Emilie Dupont is a notable inventor based in Saint Louis, France. She has made significant contributions to the field of veterinary medicine, particularly in the control of ectoparasites. Her innovative work has led to the development of new compounds that are beneficial for the health of vertebrates.
Latest Patents
Emilie holds a patent for her invention titled "(Hetero) arylacrylamides for the control of ectoparasites." This patent includes new compounds of formula (I), which are effective in controlling parasites, especially ectoparasites, in and on vertebrates. The compounds can exist in free form and in salt form, and may also include enantiomers and geometrical isomers.
Career Highlights
Emilie Dupont is associated with Novartis Tiergesundheit AG, where she has been instrumental in advancing research and development in veterinary pharmaceuticals. Her work has been recognized for its potential impact on animal health and welfare.
Collaborations
Emilie has collaborated with notable colleagues, including Noelle Gauvry and Steve Nanchen, to further her research and innovations in the field.
Conclusion
Emilie Dupont's contributions to the control of ectoparasites through her innovative compounds highlight her role as a leading inventor in veterinary medicine. Her work continues to influence the industry and improve the health of animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile